ClinVar Miner

Submissions for variant NM_006231.4(POLE):c.1306C>T (p.Pro436Ser)

dbSNP: rs1565973210
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001192999 SCV001361505 uncertain significance not specified 2019-09-20 criteria provided, single submitter clinical testing Variant summary: POLE c.1306C>T (p.Pro436Ser) results in a non-conservative amino acid change located in the exonuclease (proofreading) domain (Spier_2015). Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251188 control chromosomes (gnomAD). The variant, c.1306C>T, has been reported as a de novo variant in one individual affected with attenuated polyposis and colorectal cancer (Spier_2015). These data indicate that the variant maybe associated with the disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.